CLMT vs. DK, VTNR, BPT, CVI, ACDC, SPH, DMLP, JKS, PFHC, and NRP
Should you be buying Calumet Specialty Products Partners stock or one of its competitors? The main competitors of Calumet Specialty Products Partners include Delek US (DK), Vertex Energy (VTNR), BP Prudhoe Bay Royalty Trust (BPT), CVR Energy (CVI), ProFrac (ACDC), Suburban Propane Partners (SPH), Dorchester Minerals (DMLP), JinkoSolar (JKS), ProFrac (PFHC), and Natural Resource Partners (NRP).
Delek US (NYSE:DK) and Calumet Specialty Products Partners (NASDAQ:CLMT) are both small-cap oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment.
Delek US presently has a consensus target price of $28.56, indicating a potential upside of 4.64%. Calumet Specialty Products Partners has a consensus target price of $20.50, indicating a potential upside of 30.08%. Given Delek US's stronger consensus rating and higher possible upside, analysts plainly believe Calumet Specialty Products Partners is more favorable than Delek US.
Calumet Specialty Products Partners has a net margin of 1.55% compared to Calumet Specialty Products Partners' net margin of 0.12%. Calumet Specialty Products Partners' return on equity of 18.27% beat Delek US's return on equity.
Delek US has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Calumet Specialty Products Partners has a beta of 1.76, indicating that its share price is 76% more volatile than the S&P 500.
In the previous week, Delek US had 8 more articles in the media than Calumet Specialty Products Partners. MarketBeat recorded 12 mentions for Delek US and 4 mentions for Calumet Specialty Products Partners. Delek US's average media sentiment score of 0.53 beat Calumet Specialty Products Partners' score of -0.23 indicating that Calumet Specialty Products Partners is being referred to more favorably in the news media.
Delek US received 320 more outperform votes than Calumet Specialty Products Partners when rated by MarketBeat users. Likewise, 62.34% of users gave Delek US an outperform vote while only 50.25% of users gave Calumet Specialty Products Partners an outperform vote.
97.0% of Delek US shares are owned by institutional investors. Comparatively, 34.4% of Calumet Specialty Products Partners shares are owned by institutional investors. 0.4% of Delek US shares are owned by insiders. Comparatively, 2.9% of Calumet Specialty Products Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Calumet Specialty Products Partners has lower revenue, but higher earnings than Delek US. Calumet Specialty Products Partners is trading at a lower price-to-earnings ratio than Delek US, indicating that it is currently the more affordable of the two stocks.
Summary
Calumet Specialty Products Partners beats Delek US on 10 of the 18 factors compared between the two stocks.
Get Calumet Specialty Products Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLMT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLMT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Calumet Specialty Products Partners Competitors List
Related Companies and Tools
